Biogen and Bio-Thera Announce Positive Phase 3 Results On Tocilizumab Biosimilar

Published date02 June 2021
Subject MatterClinical Trials,Prescription Drugs,Biosimilars,Pharmaceutical Industry
AuthorWilliam James
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT